|
SCC antigen levels before chemotherapy
| |
0.095
|
0.758
|
|
NACT group (n = 63)
|
40.16 (37.24, 43.07)
| | |
|
Conventional group (n = 39)
|
33.43 (31.31, 35.56)
| | |
|
NACT group
| |
0.098
|
0.754
|
|
Chemotherapy-insensitive group (n = 32)
|
41.19 (37.29, 45.08)
| | |
|
Chemotherapy-sensitive group (n = 31)
|
39.25 (35.01, 43.50)
| | |
|
SCC antigen levels in NACT group before chemotherapy
| |
9.880
|
0.002
|
|
< 4.55 (n = 29)
|
NA a
| | |
|
≥ 4.55 (n = 34)
|
NA a
| | |
|
SCC antigen levels ≥4.55 before chemotherapy
| |
4.176
|
0.041
|
|
NACT group (n = 34)
|
36.40 (31.59, 41.22)
| | |
|
Conventional group (n = 21)
|
32.95 (30.95, 34.96)
| | |
|
SCC antigen levels in NACT group after the first chemotherapy
| |
10.869
|
0.001
|
|
< 2.70 (n = 39)
|
43.75 (42.07, 45.43)
| | |
|
≥ 2.70 (n = 24)
|
34.40 (28.99, 40.81)
| | |
